Cancer-Killing Combination Therapies Unveiled with New Drug-Screening Tool
This article is archived and only made available for historical reference. If you’d like to discover UCSF’s most recent advances in research, education and patient care, please visit the UCSF News Center. Using this technique, the researchers eradicated a devastating blood cancer and certain solid tumor cells by jointly administering drugs that are only partially effective when used as single-agent therapies.
- ▪This article is archived and only made available for historical reference.
- ▪If you’d like to discover UCSF’s most recent advances in research, education and patient care, please visit the UCSF News Center.
- ▪Using this technique, the researchers eradicated a devastating blood cancer and certain solid tumor cells by jointly administering drugs that are only partially effective when used as single-agent therapies.
UCSF News files mainly under design. We currently carry 50 of its stories.
Opening excerpt (first ~120 words) tap to expand
This article is archived and only made available for historical reference. If you’d like to discover UCSF’s most recent advances in research, education and patient care, please visit the UCSF News Center. Research April 9, 2019 Archive: Cancer-Killing Combination Therapies Unveiled with New Drug-Screening Tool Method IDs Which Targeted Therapies, Inadequate On Their Own, Can Be Paired Up to Kill Non-Responsive Cancers By Jason Alvarez Share on Facebook Share on Twitter Share on Reddit Email this article Print this article UC San Francisco scientists have designed a large-scale screen that efficiently identifies drugs that are potent cancer-killers when combined, but only weakly effective when used alone.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at UCSF News.